RESUMEN
Gonadotropin-releasing hormone (GnRH) regulates gonadal function via its stimulatory effects on gonadotropin production by pituitary gonadotrope cells. GnRH is released from the hypothalamus in pulses and GnRH pulse frequency differentially regulates follicle-stimulating hormone (FSH) and luteinizing hormone (LH) synthesis and secretion. The GnRH receptor (GnRHR) is a G protein-coupled receptor that canonically activates Gαâq/11-dependent signaling on ligand binding. However, the receptor can also couple to Gαâs and in vitro data suggest that toggling between different G proteins may contribute to GnRH pulse frequency decoding. For example, as we show here, knockdown of Gαâs impairs GnRH-stimulated FSH synthesis at low- but not high-pulse frequency in a model gonadotrope-derived cell line. We next used a Cre-lox conditional knockout approach to interrogate the relative roles of Gαâq/11 and Gαâs proteins in gonadotrope function in mice. Gonadotrope-specific Gαâq/11 knockouts exhibit hypogonadotropic hypogonadism and infertility, akin to the phenotypes seen in GnRH- or GnRHR-deficient mice. In contrast, under standard conditions, gonadotrope-specific Gαâs knockouts produce gonadotropins at normal levels and are fertile. However, the LH surge amplitude is blunted in Gαâs knockout females and postgonadectomy increases in FSH and LH are reduced both in males and females. These data suggest that GnRH may signal principally via Gαâq/11 to stimulate gonadotropin production, but that Gαâs plays important roles in gonadotrope function in vivo when GnRH secretion is enhanced.
Asunto(s)
Cromograninas/fisiología , Subunidades alfa de la Proteína de Unión al GTP Gq-G11/fisiología , Subunidades alfa de la Proteína de Unión al GTP Gs/fisiología , Gonadotrofos/metabolismo , Gonadotropinas/metabolismo , Animales , Castración , Línea Celular , Cromograninas/genética , Femenino , Fertilidad/genética , Fertilidad/fisiología , Hormona Folículo Estimulante de Subunidad beta/genética , Subunidades alfa de la Proteína de Unión al GTP Gq-G11/genética , Subunidades alfa de la Proteína de Unión al GTP Gs/genética , Regulación de la Expresión Génica/fisiología , Hormona Liberadora de Gonadotropina/fisiología , Gonadotropinas/genética , Células HEK293 , Humanos , Hormona Luteinizante/genética , Hormona Luteinizante/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Receptores LHRH/genética , Receptores LHRH/fisiología , Maduración Sexual , Transducción de Señal/fisiologíaRESUMEN
Nonshivering thermogenesis is essential for mammals to maintain body temperature. According to the canonical view, temperature is sensed by cutaneous thermoreceptors and nerve impulses transmitted to the hypothalamus, which generates sympathetic signals to ß-adrenergic receptors in brown adipocytes. The energy for heat generation is primarily provided by the oxidation of fatty acids derived from triglyceride hydrolysis and cellular uptake. Fatty acids also activate the uncoupling protein, UCP1, which creates a proton leak that uncouples mitochondrial oxidative phosphorylation from ATP production, resulting in energy dissipation as heat. Recent evidence supports the idea that in response to mild cold, ß-adrenergic signals stimulate not only lipolysis and fatty acid oxidation, but also act through the mTORC2-Akt signaling module to stimulate de novo lipogenesis. This opposing anabolic effect is thought to maintain lipid fuel stores during increased catabolism. We show here, using brown fat-specific Gs-alpha knockout mice and cultured adipocytes that, unlike mild cold, severe cold directly cools brown fat and bypasses ß-adrenergic signaling to inhibit mTORC2. This cell-autonomous effect both inhibits lipogenesis and augments UCP1 expression to enhance thermogenesis. These findings suggest a novel mechanism for overriding ß-adrenergic-stimulated anabolic activities while augmenting catabolic activities to resolve the homeostatic crisis presented by severe cold.
Asunto(s)
Tejido Adiposo Pardo/metabolismo , Cromograninas/fisiología , Frío , Subunidades alfa de la Proteína de Unión al GTP Gs/fisiología , Diana Mecanicista del Complejo 2 de la Rapamicina/metabolismo , Termogénesis , Tejido Adiposo Pardo/citología , Animales , Lipogénesis , Masculino , Diana Mecanicista del Complejo 2 de la Rapamicina/genética , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Receptores Adrenérgicos beta/genética , Receptores Adrenérgicos beta/metabolismo , Transducción de Señal , Proteína Desacopladora 1/genética , Proteína Desacopladora 1/metabolismoRESUMEN
Environmental neurotoxins such as paraquat (PQ), manganese, and 1-1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) are associated with a higher risk of Parkinson's disease (PD). These parkinsonian toxins exert certain common toxicological effects on astroglia; however, their role in the regulatory functions of astroglial secretory proteins remains unclear. In a previous study, we observed that secretogranin II (SCG2) and secretogranin III (SCG3), which are important components of the regulated secretory pathway, were elevated in PQ-activated U118 astroglia. In the current study, we used the parkinsonian toxins dopamine (DA), active metabolite of MPTP (MPP+), MnCl2, and lipopolysaccharide (LPS) as inducers, and studied the potential regulation of SCG2 and SCG3. Our results showed that all the parkinsonian toxins except LPS affected astroglial viability but did not cause apoptosis. Exposure to DA, MPP+, and MnCl2 upregulated glial fibrillary acidic protein (GFAP), a marker for astrocyte activation, and stimulated the levels of several astrocytic-derived factors. Further, DA, MPP+, and MnCl2 exposure impeded astroglial cell cycle progression. Moreover, the expression of SCG3 was elevated, while its exosecretion was inhibited in astroglia activated by parkinsonian toxins. The level of SCG2 remained unchanged. In combination with our previous findings, the results of this study indicate that SCG3 may act as a cofactor in astrocyte activation stimulated by various toxins, and the regulation of SCG3 could be involved in the toxicological mechanism by which parkinsonian toxins affect astroglia.
Asunto(s)
Astrocitos/efectos de los fármacos , Astrocitos/metabolismo , Cromograninas/fisiología , Intoxicación por MPTP/complicaciones , Neurotoxinas/toxicidad , Enfermedad de Parkinson Secundaria/etiología , Ciclo Celular/efectos de los fármacos , Cloruros/efectos adversos , Cloruros/toxicidad , Cromograninas/metabolismo , Dopamina/administración & dosificación , Dopamina/toxicidad , Proteína Ácida Fibrilar de la Glía/metabolismo , Humanos , Compuestos de Manganeso/efectos adversos , Paraquat/toxicidad , Secretogranina II/metabolismo , Secretogranina II/fisiología , Células Tumorales Cultivadas , Regulación hacia Arriba/efectos de los fármacosRESUMEN
Altered fecal levels of chromogranins (Cg) and secretogranins (Sg) are demonstrated in irritable bowel syndrome (IBS), but their role in IBS pathophysiology remains unknown. This study aimed to determine if granins are associated with bacterial composition, immune activation and IBS symptoms. Protein levels of fecal granins (CgA, CgB, SgII and SgIII) were analysed with immunoassays. Mucosal mRNA expression of granins, TPH1 and immune markers were evaluated with RT-qPCR. 16S rRNA gene sequencing was performed on fecal and mucosal bacteria. The intestinal granin profile, based on fecal protein levels and mucosal mRNA expression, could not discriminate between IBS patients (n = 88) and healthy subjects (HS, n = 33). IBS patients dominated by high fecal or mucosal granin levels, respectively, did not differ in symptom or immune profiles. Fecal-dominated and mucosal-dominated granin clusters of IBS patients and HS, demonstrated separate fecal and mucosal bacterial profiles and high fecal abundance of granins were associated with a less diverse bacterial composition and the Bacteroides enterotype. The intestinal granin profiles of IBS patients and HS are linked to the intestinal bacterial composition, diversity and enterotypes. These findings suggest that granins may be one of several host-produced factors regulating the microbiota composition of the intestine.
Asunto(s)
Cromograninas/análisis , Heces/química , Mucosa Intestinal/microbiología , Síndrome del Colon Irritable/microbiología , Adulto , Estudios de Casos y Controles , Cromograninas/fisiología , Heces/microbiología , Femenino , Humanos , Masculino , Microbiota , Persona de Mediana Edad , Proteínas/análisis , ARN Mensajero/análisisRESUMEN
BACKGROUND & AIMS: Mutations at hotspots in GNAS, which encodes stimulatory G-protein, α subunits, are detected in approximately 60% of intraductal papillary mucinous neoplasms (IPMNs) of the pancreas. We generated mice with KRAS-induced IPMNs that also express a constitutively active form of GNAS in pancreas and studied tumor development. METHODS: We generated p48-Cre; LSL-KrasG12D; Rosa26R-LSL-rtTA-TetO-GnasR201C mice (Kras;Gnas mice); pancreatic tissues of these mice express activated KRAS and also express a mutant form of GNAS (GNASR201C) upon doxycycline administration. Mice that were not given doxycycline were used as controls, and survival times were compared by Kaplan-Meier analysis. Pancreata were collected at different time points after doxycycline administration and analyzed by histology. Pancreatic ductal adenocarcinomas (PDACs) were isolated from mice and used to generate cell lines, which were analyzed by reverse transcription polymerase chain reaction, immunoblotting, immunohistochemistry, and colony formation and invasion assays. Full-length and mutant forms of yes-associated protein (YAP) were expressed in PDAC cells. IPMN specimens were obtained from 13 patients with IPMN undergoing surgery and analyzed by immunohistochemistry. RESULTS: All Kras;Gnas mice developed pancreatic cystic lesions that resemble human IPMNs; the grade of epithelial dysplasia increased with time. None of the control mice developed cystic lesions. Approximately one third of Kras;Gnas mice developed PDACs at a median of 30 weeks after doxycycline administration, whereas 33% of control mice developed PDACs. Expression of GNASR201C did not accelerate the development of PDACs compared with control mice. However, the neoplasms observed in Kras;Gnas mice were more differentiated, and expressed more genes associated with ductal phenotypes, than in control mice. PDACs isolated from Kras;Gnas mice had activation of the Hippo pathway; in cells from these tumors, phosphorylated YAP1 was sequestered in the cytoplasm, and this was also observed in human IPMNs with GNAS mutations. Sequestration of YAP1 was not observed in PDAC cells from control mice. CONCLUSIONS: In mice that express activated KRAS in the pancreas, we found expression of GNASR201C to cause development of more differentiated tumors, with gene expression pattern associated with the ductal phenotype. Expression of mutant GNAS caused phosphorylated YAP1 to be sequestered in the cytoplasm, altering tumor progression.
Asunto(s)
Proteínas Adaptadoras Transductoras de Señales/fisiología , Carcinoma Ductal Pancreático/etiología , Cromograninas/genética , Subunidades alfa de la Proteína de Unión al GTP Gs/genética , Mutación , Neoplasias Quísticas, Mucinosas y Serosas/etiología , Neoplasias Pancreáticas/etiología , Fosfoproteínas/fisiología , Proteínas Proto-Oncogénicas p21(ras)/genética , Transducción de Señal/fisiología , Proteínas Adaptadoras Transductoras de Señales/análisis , Proteínas Adaptadoras Transductoras de Señales/antagonistas & inhibidores , Animales , Proteínas de Ciclo Celular , Línea Celular Tumoral , Cromograninas/fisiología , Subunidades alfa de la Proteína de Unión al GTP Gs/fisiología , Humanos , Ratones , Fosfoproteínas/análisis , Fosfoproteínas/antagonistas & inhibidores , Proteínas Proto-Oncogénicas p21(ras)/fisiología , Proteínas Señalizadoras YAPRESUMEN
Secretogranin III (Scg3) is a member of the granin protein family that regulates the biogenesis of secretory granules. Scg3 was recently discovered as an angiogenic factor, expanding its functional role to extrinsic regulation. Unlike many other known angiogenic factors, the pro-angiogenic actions of Scg3 are restricted to pathological conditions. Among thousands of quantified endothelial ligands, Scg3 has the highest binding activity ratio to diabetic vs. healthy mouse retinas and lowest background binding to normal vessels. In contrast, vascular endothelial growth factor binds to and stimulates angiogenesis of both diabetic and control vasculature. Consistent with its role in pathological angiogenesis, Scg3-neutralizing antibodies alleviate retinal vascular leakage in mouse models of diabetic retinopathy and retinal neovascularization in oxygen-induced retinopathy mice. This review summarizes our current knowledge of Scg3 as a regulatory protein of secretory granules, highlights its new role as a highly disease-selective angiogenic factor, and envisions Scg3 inhibitors as "selective angiogenesis blockers" for targeted therapy.
Asunto(s)
Inductores de la Angiogénesis/metabolismo , Cromograninas/fisiología , Retinopatía Diabética , Neovascularización Patológica/genética , Animales , Cromograninas/genética , Retinopatía Diabética/genética , Retinopatía Diabética/metabolismo , Retinopatía Diabética/patología , Humanos , Ratones , Neovascularización Patológica/metabolismo , Neovascularización Patológica/patología , Vasos Retinianos/metabolismo , Vasos Retinianos/patología , Vesículas Secretoras/genética , Vesículas Secretoras/metabolismo , Vesículas Secretoras/patologíaRESUMEN
Genome sequencing efforts have identified virtually all of the important mutations in adult myeloid malignancies. More recently, population studies have identified cancer-associated variants in the blood of otherwise healthy individuals as they age, a phenomenon termed clonal hematopoiesis of indeterminate potential (CHIP). This suggests that these mutations may occur in hematopoietic stem cells (HSCs) long before any clinical presentation but are not necessarily harbingers of transformation because only a fraction of individuals with CHIP develop hematopoietic pathologies. Delineation between CHIP variants that predispose for disease versus those that are more benign could be used as a prognostic factor to identify individuals at greater risk for transformation. To achieve this, the biological impact of CHIP variants on HSC function must be validated. One variant that has been identified recurrently in CHIP is a gain-of-function missense mutation in the imprinted gene GNAS (Guanine Nucleotide Binding Protein, Alpha Stimulating). In this study, we examined the effect of the GNASR201C variant on HSC function. Ectopic expression of GNASR201C supported transplantable HSC activity and improved lymphoid output in secondary recipients. Because declining lymphoid output is a hallmark of aging, GNASR201C mutations may sustain lymphoid-biased HSCs over time and maintain them in a developmental state favorable for transformation.
Asunto(s)
Cromograninas/genética , Subunidades alfa de la Proteína de Unión al GTP Gs/genética , Mutación con Ganancia de Función , Hematopoyesis/genética , Mutación Missense , Animales , Trasplante de Médula Ósea , Recuento de Células , Senescencia Celular , Cromograninas/fisiología , ADN Complementario/genética , Subunidades alfa de la Proteína de Unión al GTP Gs/fisiología , Redes Reguladoras de Genes , Genes Reporteros , Vectores Genéticos/genética , Hematopoyesis/fisiología , Células Madre Hematopoyéticas , Humanos , Lentivirus/genética , Linfopoyesis/genética , Ratones , Ratones Endogámicos C57BL , Transducción Genética , Quimera por TrasplanteRESUMEN
We previously reported that 3T3-L1 cells express a functional sweet taste receptor possibly as a T1R3 homomer that is coupled to Gs and negatively regulates adipogenesis by a Gαs-mediated but cAMP-independent mechanism. Here, we show that stimulation of this receptor with sucralose or saccharin induced disassembly of the microtubules in 3T3-L1 preadipocytes, which was attenuated by overexpression of the dominant-negative mutant of Gαs (Gαs-G226A). In contrast, overexpression of the constitutively active mutant of Gαs (Gαs-Q227L) as well as treatment with cholera toxin or isoproterenol but not with forskolin caused disassembly of the microtubules. Sweetener-induced microtubule disassembly was accompanied by activation of RhoA and Rho-associated kinase (ROCK). This was attenuated with by knockdown of GEF-H1, a microtubule-localized guanine nucleotide exchange factor for Rho GTPase. Furthermore, overexpression of the dominant-negative mutant of RhoA (RhoA-T19N) blocked sweetener-induced dephosphorylation of Akt and repression of PPARγ and C/EBPα in the early phase of adipogenic differentiation. These results suggest that the T1R3 homomeric sweet taste receptor negatively regulates adipogenesis through Gαs-mediated microtubule disassembly and consequent activation of the Rho/ROCK pathway.
Asunto(s)
Adipogénesis/fisiología , Cromograninas/fisiología , Subunidades alfa de la Proteína de Unión al GTP Gs/fisiología , Microtúbulos/fisiología , Receptores Acoplados a Proteínas G/fisiología , Proteínas de Unión al GTP rho/metabolismo , Células 3T3-L1 , Animales , Transferencia Resonante de Energía de Fluorescencia , RatonesRESUMEN
Diabetic retinopathy (DR) is a leading cause of vision loss with retinal vascular leakage and/or neovascularization. Current antiangiogenic therapy against vascular endothelial growth factor (VEGF) has limited efficacy. In this study, we applied a new technology of comparative ligandomics to diabetic and control mice for the differential mapping of disease-related endothelial ligands. Secretogranin III (Scg3) was discovered as a novel disease-associated ligand with selective binding and angiogenic activity in diabetic but not healthy vessels. In contrast, VEGF bound to and induced angiogenesis in both diabetic and normal vasculature. Scg3 and VEGF signal through distinct receptor pathways. Importantly, Scg3-neutralizing antibodies alleviated retinal vascular leakage in diabetic mice with high efficacy. Furthermore, anti-Scg3 prevented retinal neovascularization in oxygen-induced retinopathy mice, a surrogate model for retinopathy of prematurity (ROP). ROP is the most common cause of vision impairment in children, with no approved drug therapy. These results suggest that Scg3 is a promising target for novel antiangiogenic therapy of DR and ROP.
Asunto(s)
Inhibidores de la Angiogénesis/uso terapéutico , Cromograninas/fisiología , Retinopatía Diabética/tratamiento farmacológico , Animales , Permeabilidad Capilar , Cromograninas/antagonistas & inhibidores , Secuenciación de Nucleótidos de Alto Rendimiento , Ligandos , Sistema de Señalización de MAP Quinasas , Masculino , Ratones , Ratones Endogámicos C57BL , Transducción de Señal , Factor A de Crecimiento Endotelial Vascular/antagonistas & inhibidores , Factor A de Crecimiento Endotelial Vascular/fisiologíaRESUMEN
Chromogranins (Cgs) are acidic proteins implicated in several physiological processes, including the biogenesis and sorting of secretory vesicles, the generation of bioactive peptides, and the accumulation of soluble species inside large dense core vesicles (LDCV). Indeed, Cgs are the main protein component of the vesicular matrix in LDCV, and they are involved in the concentration of soluble species like neurotransmitters and calcium. Experiments using electrochemical techniques such amperometry, patch amperometry, and intracellular electrochemistry have clarified the functional roles of Cgs in the accumulation and release of catecholamines. We have focused this review at a single event of exocytosis of chromaffin cells from three mouse strains lacking Cgs. Accordingly, in this brief review, we will focus on the role of Cgs in maintaining the intravesicular environment of secretory vesicles and in exocytosis, bringing together the most recent findings from studies on adrenal chromaffin cells.
Asunto(s)
Cromograninas/fisiología , Vías Secretoras , Animales , Catecolaminas/fisiología , Células Cromafines/citología , Cromograninas/genética , Exocitosis , Ratones , Neurotransmisores/fisiología , Vesículas Secretoras/fisiologíaRESUMEN
The neurotoxins paraquat (PQ) and dopamine (DA or 6-OHDA) cause apoptosis of dopaminergic neurons in the substantia nigra pars compacta (SNpc), reproducing an important pathological feature of Parkinson's disease (PD). Secretogranin III (SCG3), a member of the multifunctional granin family, plays a key role in neurotransmitter storage and transport and in secretory granule biogenesis, which involves the uptake of exogenous toxins and endogenous "toxins" in neuroendocrine cells. However, the molecular mechanisms of neurotoxin-induced apoptosis in dopaminergic neurons and the role of SCG3-associated signaling pathways in neuroendocrine regulation are unclear. To address this, we used PQ- and DA-induced apoptosis in SH-SY5Y human dopaminergic cells as an in vitro model to investigate the association between SCG3 expression level and apoptosis. SCG3 was highly expressed in SH-SY5Y cells, and SCG3 mRNA and protein levels were dramatically decreased after PQ treatment. Apoptosis induced by PQ is associated with caspase activation and decreased SCG3 expression, and restoration of SCG3 expression is observed after treatment with caspase inhibitors. Overexpressed SCG3 in nonneuronal cells and endogenous SCG3 in SH-SY5Y cells are cleaved into specific fragments by recombinant caspase-3 and -7, but the fragments were not detected in PQ-treated SH-SY5Y cells. Therefore, SCG3 may be involved in apoptosis signal transduction as a caspase substrate, leading to loss of its original biological functions. In addition, SCG3 may be a pivotal component of the neuroendocrine pathway and play an important role in neuronal communication and neurotransmitter release, possibly representing a new potential target in the course of PD pathogenesis.
Asunto(s)
Apoptosis/efectos de los fármacos , Cromograninas/fisiología , Neuronas Dopaminérgicas/efectos de los fármacos , Proteínas del Tejido Nervioso/fisiología , Neurotoxinas/toxicidad , Paraquat/toxicidad , Clorometilcetonas de Aminoácidos/farmacología , Apoptosis/fisiología , Caspasa 3/metabolismo , Caspasa 7/metabolismo , Inhibidores de Caspasas/farmacología , Línea Celular Tumoral/efectos de los fármacos , Línea Celular Tumoral/metabolismo , Cromograninas/biosíntesis , Cromograninas/genética , Dopamina/toxicidad , Neuronas Dopaminérgicas/metabolismo , Regulación hacia Abajo/efectos de los fármacos , Células HEK293/metabolismo , Humanos , Proteínas del Tejido Nervioso/biosíntesis , Proteínas del Tejido Nervioso/genética , Neuroblastoma/patología , Oxidopamina/toxicidad , ARN Mensajero/biosíntesis , ARN Mensajero/genética , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/fisiología , Especificidad por SustratoRESUMEN
The chromogranins (chromogranin A and chromogranin B), secretogranins (secretogranin II and secretogranin III), and additional related proteins (7B2, NESP55, proSAAS, and VGF) that together comprise the granin family subserve essential roles in the regulated secretory pathway that is responsible for controlled delivery of peptides, hormones, neurotransmitters, and growth factors. Here we review the structure and function of granins and granin-derived peptides and expansive new genetic evidence, including recent single-nucleotide polymorphism mapping, genomic sequence comparisons, and analysis of transgenic and knockout mice, which together support an important and evolutionarily conserved role for these proteins in large dense-core vesicle biogenesis and regulated secretion. Recent data further indicate that their processed peptides function prominently in metabolic and glucose homeostasis, emotional behavior, pain pathways, and blood pressure modulation, suggesting future utility of granins and granin-derived peptides as novel disease biomarkers.
Asunto(s)
Cromograninas/química , Cromograninas/fisiología , Animales , Biomarcadores/química , Biomarcadores/metabolismo , Cromograninas/uso terapéutico , Células Endocrinas/efectos de los fármacos , Células Endocrinas/metabolismo , Subunidades alfa de la Proteína de Unión al GTP Gs/química , Subunidades alfa de la Proteína de Unión al GTP Gs/fisiología , Subunidades alfa de la Proteína de Unión al GTP Gs/uso terapéutico , Humanos , Factores de Crecimiento Nervioso/química , Factores de Crecimiento Nervioso/fisiología , Factores de Crecimiento Nervioso/uso terapéutico , Células Neuroendocrinas/efectos de los fármacos , Células Neuroendocrinas/metabolismo , Proteína 7B2 Secretora Neuroendocrina/química , Proteína 7B2 Secretora Neuroendocrina/fisiología , Proteína 7B2 Secretora Neuroendocrina/uso terapéutico , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Neuropéptidos/química , Neuropéptidos/fisiología , Neuropéptidos/uso terapéutico , Fragmentos de Péptidos/química , Fragmentos de Péptidos/fisiología , Fragmentos de Péptidos/uso terapéutico , Vesículas Secretoras/efectos de los fármacos , Vesículas Secretoras/metabolismo , Homología de Secuencia de AminoácidoRESUMEN
Gut inflammation is characterized by mucosal recruitment of activated cells from both the innate and adaptive immune systems. In addition to immune cells, inflammation in the gut is associated with an alteration in enteric endocrine cells and various biologically active compounds produced by these cells. Although the change in enteric endocrine cells or their products is considered to be important in regulating gut physiology (motility and secretion), it is not clear whether the change plays any role in immune activation and in the regulation of gut inflammation. Due to the strategic location of enteric endocrine cells in gut mucosa, these gut hormones may play an important role in immune activation and promotion of inflammation in the gut. This review addresses the research on the interface between immune and endocrine systems in gastrointestinal (GI) pathophysiology, specifically in the context of two major products of enteric endocrine systems, namely serotonin (5-hydroxytryptamine: 5-HT) and chromogranins (Cgs), in relation to immune activation and generation of inflammation. The studies reviewed in this paper demonstrate that 5-HT activates the immune cells to produce proinflammatory mediators and by manipulating the 5-HT system it is possible to modulate gut inflammation. In the case of Cgs the scenario is more complex, as this hormone has been shown to play both proinflammatory and anti-inflammatory functions. It is also possible that interaction between 5-HT and Cgs may play a role in the modulation of immune and inflammatory responses. In addition to enhancing our understanding of immunoendocrine interaction in the gut, the data generated from the these studies may have implications in understanding the role of gut hormone in the pathogenesis of both GI and non-GI inflammatory diseases which may lead ultimately to improved therapeutic strategies in inflammatory disorders.
Asunto(s)
Cromograninas/fisiología , Colitis/fisiopatología , Inmunidad Mucosa/fisiología , Neuroinmunomodulación/fisiología , Serotonina/fisiología , Animales , Enfermedad Celíaca/fisiopatología , Colitis/inmunología , Células Enterocromafines/metabolismo , Células Enteroendocrinas/metabolismo , Motilidad Gastrointestinal/fisiología , Humanos , Inmunidad Mucosa/efectos de los fármacos , Síndrome del Colon Irritable/fisiopatología , Ratones , Ratones Noqueados , Ratas , Receptores de Serotonina/efectos de los fármacos , Receptores de Serotonina/fisiología , Antagonistas de la Serotonina/farmacología , Agonistas de Receptores de Serotonina/farmacología , Triptófano Hidroxilasa/deficiencia , Triptófano Hidroxilasa/genéticaRESUMEN
Secretory granules in endocrine cells selectively store bioactive peptide hormones and amines, which are secreted in a regulated manner upon appropriate stimulation. In addition to bioactive substances, various proteins and lipids characteristic of secretory granules are likely recruited to a restricted space at the trans-Golgi Network (TGN), and the space then matures to the secretory granule. Although experimental findings so far have strongly suggested that aggregation- and receptor-mediated processes are essential for the formation of secretory granules, the putative link between these two processes remains to be clarified. Recently, secretogranin III (SgIII) has been identified as a specific binding protein for chromogranin A (CgA), a representative constituent of the core aggregate within secretory granules, and it was later revealed that SgIII can also bind to the cholesterol-rich membrane domain at the TGN. Based on its multifaceted binding properties, SgIII may act as a central player in the formation of cholesterol-rich membrane platforms. Upon these platforms, essential processes for secretory granule biogenesis coordinately occur; that is, selective recruitment of prohormones, processing and modifying of prohormones, and condensation of mature hormones as an aggregate. This review summarizes the findings and theoretical concepts on the issue to date and then focuses on the putative role of SgIII in secretory granule biogenesis in endocrine cells.
Asunto(s)
Cromograninas/fisiología , Hormonas/metabolismo , Vesículas Secretoras/fisiología , Vesículas Secretoras/ultraestructura , Animales , Colesterol/análisis , Colesterol/metabolismo , Cromogranina A/metabolismo , Hormonas/biosíntesis , Humanos , Membranas Intracelulares/química , Membranas Intracelulares/metabolismo , Modelos Teóricos , Neuropéptidos/biosíntesis , Red trans-Golgi/metabolismo , Red trans-Golgi/ultraestructuraRESUMEN
The granin protein family is composed of two chromogranin and five secretogranin members that are acidic, heat-stable proteins in secretory granules in cells of the nervous and endocrine systems. We report that there is little evidence for evolutionary relationships among the granins except for the chromogranin group. The main granin members, including chromogranin A and B, and secretogranin II are moderately conserved in the vertebrates. Several small bioactive peptides can be generated by proteolysis from those homologous domains existing within the granin precursors, reflecting the conservation of biological activities in different vertebrates. In this context, we focus on reviewing the distribution and function of the major granin-derived peptides, including vasostatin, bovine CgB(1-41) and secretoneurin in vertebrate endocrine systems, especially those associated with growth, glucose metabolism and reproduction.
Asunto(s)
Cromograninas/fisiología , Sistema Endocrino/fisiología , Evolución Molecular , Neuropéptidos/fisiología , Hormonas Peptídicas/fisiología , Secuencia de Aminoácidos , Animales , Cromograninas/química , Cromograninas/genética , Sistema Endocrino/metabolismo , Humanos , Datos de Secuencia Molecular , Neuropéptidos/química , Neuropéptidos/genética , Neuropéptidos/metabolismo , Hormonas Peptídicas/química , Hormonas Peptídicas/genética , Hormonas Peptídicas/metabolismo , Filogenia , Homología de Secuencia de AminoácidoRESUMEN
Mast cells are granular immunocytes that reside in the body's barrier tissues. These cells orchestrate inflammatory responses. Proinflammatory mediators are stored in granular structures within the mast cell cytosol. Control of mast cell granule exocytosis is a major therapeutic goal for allergic and inflammatory diseases. However, the proteins that control granule biogenesis and abundance in mast cells have not been elucidated. In neuroendocrine cells, whose dense core granules are strikingly similar to mast cell granules, granin proteins regulate granulogenesis. Our studies suggest that the Secretogranin III (SgIII) protein is involved in secretory granule biogenesis in mast cells. SgIII is abundant in mast cells, and is organized into vesicular structures. Our results show that over-expression of SgIII in mast cells is sufficient to cause an expansion of a granular compartment in these cells. These novel granules store inflammatory mediators that are released in response to physiological stimuli, indicating that they function as bona fide secretory vesicles. In mast cells, as in neuroendocrine cells, we show that SgIII is complexed with Chromogranin A (CgA). CgA is granulogenic when complexed with SgIII. Our data show that a novel non-granulogenic truncation mutant of SgIII (1-210) lacks the ability to interact with CgA. Thus, in mast cells, a CgA-SgIII complex may play a key role in secretory granule biogenesis. SgIII function in mast cells is unlikely to be limited to its partnership with CgA, as our interaction trap analysis suggests that SgIII has multiple binding partners, including the mast cell ion channel TRPA1.
Asunto(s)
Comunicación Celular/inmunología , Cromogranina A/metabolismo , Cromograninas/metabolismo , Mastocitos/metabolismo , Vesículas Secretoras/metabolismo , Animales , Comunicación Celular/genética , Línea Celular , Línea Celular Tumoral , Cromogranina A/biosíntesis , Cromogranina A/genética , Cromogranina A/fisiología , Cromograninas/biosíntesis , Cromograninas/genética , Cromograninas/fisiología , Humanos , Leucemia de Mastocitos/genética , Leucemia de Mastocitos/inmunología , Leucemia de Mastocitos/metabolismo , Mastocitos/inmunología , Mastocitos/patología , Mastocitoma/genética , Mastocitoma/inmunología , Mastocitoma/metabolismo , Ratones , Células PC12 , Ratas , Vesículas Secretoras/genética , Vesículas Secretoras/inmunología , Vesículas Secretoras/patología , Eliminación de SecuenciaRESUMEN
Chromogranins (Cgs) are the major soluble proteins of dense-core secretory vesicles. Chromaffin cells from Chga null mice [chromogranin A knock-out (CgA-KO)] exhibited approximately 30% reduction in the content and in the release of catecholamines compared with wild type. This was because of a lower secretion per single exocytotic event, rather than to a lower frequency of exocytotic events. Cell incubation with L-DOPA produced an increase in the vesicular amine content of wild-type, but not CgA-KO vesicles. In contrast, intracellular electrochemistry showed that L-DOPA produced a significantly larger increase in cytosolic amines in CgA-KO cells than in the wild type. These data indicate that the mechanisms for vesicular accumulation in CgA-KO cells were fully saturated. Patch-amperometry recordings showed a delayed initiation of the amperometric signal after vesicle fusion, whereas no changes were observed in vesicle size or fusion pore kinetics despite the smaller amine content. We conclude that intravesicular proteins are highly efficient systems directly implicated in transmitter accumulation and in the control of neurosecretion.
Asunto(s)
Células Cromafines/fisiología , Cromograninas/fisiología , Exocitosis/fisiología , Glándulas Suprarrenales/citología , Animales , Catecolaminas/metabolismo , Células Cultivadas , Células Cromafines/efectos de los fármacos , Cromogranina A/deficiencia , Dopaminérgicos/farmacología , Electroquímica/métodos , Exocitosis/efectos de los fármacos , Levodopa/farmacología , Fusión de Membrana/fisiología , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Probabilidad , Tirosina 3-Monooxigenasa/metabolismoRESUMEN
The gene trap technique is a powerful approach for characterizing and mutating genes in the mouse. We used this method to identify a mouse gene of unknown function and to establish a mutant mouse line. We subsequently identified one gene, denoted Ayu17-449, on mouse chromosome 3 that comprised 14 exons encoding 1920 amino acids with a granin motif in its N-terminal sequence. In adult mice, this gene was highly expressed in the brain, heart, lung, muscle, stomach, and kidney. The insertion of a trap vector into the second intron of this gene resulted in the null mutation. Homozygous mice for these mutation died by 1 day after birth. Mutant mice showed a loss of acidic granules in the proximal convoluted tubules of the kidney. Our data demonstrates that Ayu17-449 is important for mouse survival.
Asunto(s)
Cromograninas/fisiología , Genes Letales/fisiología , Vectores Genéticos , Riñón/patología , Empalme Alternativo , Secuencia de Aminoácidos , Animales , Northern Blotting , Células Cultivadas , Electroporación , Femenino , Heterocigoto , Homocigoto , Kanamicina Quinasa/genética , Kanamicina Quinasa/metabolismo , Riñón/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Datos de Secuencia Molecular , Mutación/genética , Fenotipo , ARN Mensajero/genética , ARN Mensajero/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Distribución Tisular , beta-Galactosidasa/genética , beta-Galactosidasa/metabolismoRESUMEN
In the present review, we discuss the sorting mechanism of peptide hormones and the biogenesis mechanism of secretory granules in view of the significance of the high cholesterol composition of secretory granule membranes. Peptide hormones and granin-family proteins are sorted to immature budding granules at the trans-Golgi network in neuroendocrine cells. Two models have been proposed for granule protein sorting: "aggregation-mediated sorting" and "receptor-mediated sorting". In the aggregation-mediated sorting model, granin-family proteins such as chromogranin A and B form aggregates with peptide hormones in weakly acidic, high calcium milieu of the budding granules. Chromogranins have a disulfide loop at their N-terminal at which they bind to the budding granular membrane, and bring hormones to the granules. In the receptor-mediated sorting model, carboxypeptidase E and/or secretogranin III function as a sorting receptor for peptide hormones. They bind peptide hormones, such as proopiomelanocortin, and have a high-cholesterol-binding domain. Since secretory granule membranes contain high levels of cholesterol, peptide hormones are brought to the secretory granules by these receptors. Although the two models have been conflicting, we suggest that both are cooperative and compensating each other for the sorting of peptide hormones and the biogenesis of secretory granules.